Juan Carlos Jaramillo
Fortune : 2 M $ au 31/08/2026
Fortune : 2 M $ au 31/08/2026
Dr. Juan Carlos Jaramillo is a Chief Medical Officer at Valneva SE.
Dr. Jaramillo was previously employed as a SVP, Head-Global Market Access & Pricing by Daiichi Sankyo Europe GmbH, a Senior VP-Medical Affairs & Clinical Development by Grünenthal GmbH, and a Senior Vice President-Medical Affairs by Grünenthal USA, Inc. He received his undergraduate degree from Universidad Central del Este and a doctorate degree from Universidad Central del Este.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALNEVA SE 0,37% | 31/12/2025 | 699 305 ( 0,37% ) | 2 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VALNEVA SE | Directeur Technique/Scientifique/R&D | 01/10/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Daiichi Sankyo Europe GmbH
Daiichi Sankyo Europe GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Manufactures medicines for pain management and related diseases | Directeur Technique/Scientifique/R&D | 01/04/2013 |
Grünenthal USA, Inc.
Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Daiichi Sankyo Europe GmbH
Daiichi Sankyo Europe GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Manufactures medicines for pain management and related diseases | Health Technology |
Universidad Central del Este
Universidad Central del Este Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valneva SE
Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Grünenthal USA, Inc.
Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national